Clinical Trials
Nipah Virus Vaccines Enter Clinical Trials in Bangladesh
Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection.
While Nipah case numbers remain low, climate change...
Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...
Clinical Trials
CDSCO Moves to Online Submission for CGTP Trial Applications
As part of its continued efforts to streamline operations through digitisation, the Central Drugs Standard Control Organisation (CDSCO) has transitioned from offline to online acceptance of clinical trial applications for cell and gene therapies products (CGTP).
The agency has also...
Clinical Trials
Adaptive RCTs: Transforming Clinical Trials for Efficiency
Randomised controlled trials (RCTs) have long been the gold standard of clinical trials, with the most robust evidence of safety and effectiveness of new medicines. But the traditional RCT model—characterised by strict protocols, predetermined sample sizes, and rigid timelines—is...
Clinical Trials
Big Data Integration Transforming Clinical Trials
In the years that have gone by, the big data integration within clinical trials has gone on to emerge as a very transformative force within the healthcare industry, especially in Asia. As Asia continues to experience fast economic growth, advancement...
Clinical Trials
Clinical Trial Supplies Market Worth $8.18 Billion by 2030
The market for clinical trial supplies is about to change a lot because there is a growing need for new ways to help people with their health and because medical research is making progress. As the world changes, the...
Business & Industry
Asia’s CROs VCs: Blurring Service Provider & Investor Roles
In a time characterized by accelerated innovation and ever-more complicated clinical environments, Asia is witnessing an invigorating shift in the role of Contract Research Organizations (CROs). Once seen as service organizations that assist in the pharmaceutical and biotech product...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read